Analysis of image data from the EuroNet PHL-C2 trial indicates a potential reduction in injected F-18 FDG activities in children: a proposal to update the EANM Paediatric Dosage Card.

Autor: Tran-Gia J; Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany. Tran_J@ukw.de., Eberlein U; Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany., Lassmann M; Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany., Mauz-Körholz C; Department of Paediatric Oncology, Justus-Liebig-University Giessen, Giessen, Germany., Körholz D; Department of Paediatric Oncology, Justus-Liebig-University Giessen, Giessen, Germany., Zuccetta P; Nuclear Medicine Unit, Department of Medicine - DIMED, University Hospital of Padua, Padua, Italy., Bar-Sever Z; Schneider Children's Medical Center, Petach Tikva, Israel., Rosner U; Department of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany., Georgi TW; Department of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany., Sabri O; Department of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany., Kluge R; Department of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany., Piccardo A; Department of Nuclear Medicine, E.O. 'Ospedali Galliera', Genoa, Italy., Kurch L; Department of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.
Jazyk: angličtina
Zdroj: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Jan; Vol. 51 (2), pp. 405-411. Date of Electronic Publication: 2023 Sep 20.
DOI: 10.1007/s00259-023-06396-w
Abstrakt: Background: The aim of this work is to provide the currently missing evidence that may allow an update of the Paediatric Dosage Card provided by the European Association of Nuclear Medicine (EANM) for conventional PET/CT systems.
Methods: In a total of 2082 consecutive [ 18 F]FDG-PET scans performed within the EuroNet-PHL-C2 trial, the administered [ 18 F]FDG activity was compared to the activity recommended by the EANM Paediatric Dosage Card. None of these scans had been rejected beforehand by the reference nuclear medicine panel of the trial because of poor image quality. For detailed quality assessment, a subset of 91 [ 18 F]FDG-PET scans, all performed in different patients at staging, was selected according to pre-defined criteria, which (a) included only patients who had received substantially lower activities than those recommended by the EANM Paediatric Dosage Card, and (b) included as wide a range of different PET systems and imaging parameters as possible to ensure that the conclusions drawn in this work are as generally valid as possible. The image quality of the subset was evaluated visually by two independent readers using a quality scoring system as well as analytically based on a volume-of-interest analysis in 244 lesions and the healthy liver. Finally, recommendations for an update of the EANM Paediatric Dosage Card were derived based on the available data.
Results: The activity recommended by the EANM Paediatric Dosage Card was undercut by a median of 99.4 MBq in 1960 [ 18 F]FDG-PET scans and exceeded by a median of 15.1 MBq in 119 scans. In the subset analysis (n = 91), all image data were visually classified as clinically useful. In addition, only a very weak correlation (r = 0.06) between activity reduction and tumour-to-background ratio was found. Due to the intended heterogeneity of the dataset, the noise could not be analysed statistically sound as the high range of different imaging variables resulted in very small subsets. Finally, a suggestion for an update of the EANM Paediatric Dosage Card was developed, based on the analysis presented, resulting in a mean activity reduction by 39%.
Conclusion: The results of this work allow for a conservative update of the EANM Paediatric Dosage Card for [ 18 F]FDG-PET/CT scans performed with conventional PET/CT systems.
(© 2023. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje